PRGO News and Press, Perrigo Company plc From 04/04/19

Private equity shops Apollo Global Management and CVC Capital Partners are apparently bidding  for Perrigo's ( PRGO +2.6% ) generic pharmaceuticals unit according to informed sources who add that the business could fetch more than $2.5B. More news on: Perrigo Company plc, Akorn, In...

The FDA tentatively approves Perrigo's (NYSE: PRGO ) generic version of Sernivo (betamethasone dipropionate) Spray 0.05%. Perrigo previously settled its Sernivo patent dispute with Promius Pharma. More news on: Perrigo Company plc, Healthcare stocks news, Read more ...

DUBLIN , April 4, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable, Self-Care Products ™ " , today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic v...

In June of 2015, I started a series of articles in which I highlight the stocks from the Dividend Champions list that have the highest and the lowest Percent Above Average Yield (PAAY) over the past one year and over the past five years. PAAY is a measure of how much a stock is above (high PAA...

DUBLIN , April 2, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) a leading global provider of "Quality, Affordable, Self-Care Products™",  today announced that it has settled its Hatch-Waxman litigation relating to its tentatively-approved generic version&#x...

In testimony before a Senate Appropriations Subcommittee about the FDA's 2020 budget request, Commissioner Scott Gottlieb, M.D. emphasized the importance of a relatively paltry additional $55M to continue the agency's work combating the opioid crisis. More news on: Endo International plc...

Privately held Purdue Pharma LP has agreed to pay the state of Oklahoma $270M to settle litigation from the AG's office over its role in the opioid crisis there. More news on: Endo International plc, INSYS Therapeutics, Inc., Titan Pharmaceuticals, Inc., Healthcare stocks news, Stocks on...

Company met all milestones in 2018 and this year expects to report Phase III top-line results for Epsolay ® and TWIN, potentially best-in-class papulopustular rosacea and acne vulgaris topical medications Recent approval of Perrigo's generic acyclovir cream, 5%, has already prov...

DUBLIN , March 20, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that Ray Silcock will join the Company as Executive Vice President and Chief Financial Officer, effective March 25, 2019 . Ray will lead the global finance, tax, internal audit, investor...

Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015. With only a few minor exceptions, this is true for most companies, especially the ph...